- /
- Supported exchanges
- / US
- / PLSE.NASDAQ
Pulse Biosciences Inc (PLSE NASDAQ) stock market data APIs
Pulse Biosciences Inc Financial Data Overview
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pulse Biosciences Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Pulse Biosciences Inc data using free add-ons & libraries
Get Pulse Biosciences Inc Fundamental Data
Pulse Biosciences Inc Fundamental data includes:
- Net Revenue: 751 K
- EBITDA: -76 402 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-04
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pulse Biosciences Inc News
New
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
On May 11, 2026, Paul A. LaViolette, Chief Executive Officer of Pulse Biosciences(NASDAQ:PLSE), a developer of non-thermal bioelectric treatments, reported the direct purchase of 15,000 shares of comm...
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
Key Points CEO Paul LaViolette acquired 15,000 shares for a total cost of ~$295,000 on May 11, 2026. This transaction increased direct holdings by ~1,773.05%, raising the total to 15,846 shares post-...
Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial
Pulse Biosciences, Inc. (NASDAQ:PLSE) is one of the must-buy small cap stocks to buy. On April 7, Pulse Biosciences, Inc. (NASDAQ:PLSE) announced that it had enrolled the first patients in NANOPULSE-A...
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
Pulse Biosciences PLSE recently announced the enrollment of the first patients in its NANOPULSE-AF investigational device exemption (IDE) pivotal study, marking a significant milestone in the company�...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.